| 24125830
|
Respiratory virus detection in nasopharyngeal aspirate versus bronchoalveolar lavage is dependent on virus type in children with chronic respiratory symptoms. |
J Clin Virol |
2013 |
Wurzel DF;Marchant JM;Clark JE;Mackay IM;Wang CY;Sloots TP;Upham JW;Yerkovich ST;Masters IB;Baker PJ;Anderson-James S;Chang AB |
View
More |
| 32094077
|
Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. |
Respir Investig |
2020 |
Yamaya M;Nishimura H;Deng X;Sugawara M;Watanabe O;Nomura K;Shimotai Y;Momma H;Ichinose M;Kawase T |
View
More |
| 32674356
|
Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells. |
J Clin Med |
2020 |
Min JS;Kim DE;Jin YH;Kwon S |
View
More |
| 32907596
|
In vitro virucidal activity of Echinaforce(R), an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2. |
Virol J |
2020 |
Signer J;Jonsdottir HR;Albrich WC;Strasser M;Zust R;Ryter S;Ackermann-Gaumann R;Lenz N;Siegrist D;Suter A;Schoop R;Engler OB |
View
More |
| 33444702
|
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system. |
Antiviral Res |
2021 |
Zhu Q;Zhang Y;Wang L;Yao X;Wu D;Cheng J;Pan X;Liu H;Yan Z;Gao L |
View
More |
| 33634160
|
Plant-Derived Food Grade Substances (PDFGS) Active Against Respiratory Viruses: A Systematic Review of Non-clinical Studies. |
Front Nutr |
2021 |
Umeoguaju FU;Ephraim-Emmanuel BC;Patrick-Iwuanyanwu KC;Zelikoff JT;Orisakwe OE |
View
More |
| 33713730
|
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. |
Antiviral Res |
2021 |
Milani M;Donalisio M;Bonotto RM;Schneider E;Arduino I;Boni F;Lembo D;Marcello A;Mastrangelo E |
View
More |
| 34012431
|
CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein. |
Front Immunol |
2021 |
Taborska P;Strizova Z;Stakheev D;Sojka L;Bartunkova J;Smrz D |
View
More |
| 34350810
|
Epidemiological and co-infection characteristics of common human coronaviruses in Shanghai, 2015-2020: a retrospective observational study. |
Emerg Microbes Infect |
2021 |
Kong D;Zheng Y;Hu L;Chen J;Wu H;Teng Z;Zhou Y;Qiu Q;Lu Y;Pan H |
View
More |
| 34634321
|
Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2. |
J Virol Methods |
2022 |
Schirtzinger EE;Kim Y;Davis AS |
View
More |
| 34835005
|
Apoptosis Enhances the Replication of Human Coronavirus OC43. |
Viruses |
2021 |
Maharjan S;Kang M;Kim J;Kim D;Park S;Kim M;Baek K;Lee Y;Kwon HJ |
View
More |
| 35666671
|
TiO(2) Nanostructures That Reduce the Infectivity of Human Respiratory Viruses Including SARS-CoV-2. |
ACS Biomater Sci Eng |
2022 |
Jaggessar A;Velic A;Yarlagadda PK;Spann K |
View
More |
| 36652473
|
Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2. |
Proc Natl Acad Sci U S A |
2023 |
Liu D;Chen C;Chen D;Zhu A;Li F;Zhuang Z;Mok CKP;Dai J;Li X;Jin Y;Chen Z;Sun J;Wang Y;Li Y;Zhang Y;Wen L;Zhang Z;Zhuo J;Wang J;Ran W;Wang D;Zhang S;Tang Y;Li S;Lai X;Wei P;Yuan J;Chen F;Huang S;Sun F;Qian Z;Tan W;Zhao J;Peiris M;Zhao J |
View
More |
| 37112913
|
Changes in the Etiology of Acute Respiratory Infections among Children in Novosibirsk, Russia, between 2019 and 2022: The Impact of the SARS-CoV-2 Virus. |
Viruses |
2023 |
Kurskaya OG;Prokopyeva EA;Sobolev IA;Solomatina MV;Saroyan TA;Dubovitskiy NA;Derko AA;Nokhova AR;Anoshina AV;Leonova NV;Simkina OA;Komissarova TV;Shestopalov AM;Sharshov KA |
View
More |
| 37668370
|
One for all-human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses. |
J Virol |
2023 |
Daniels A;Fletcher S;Kerr HEM;Kratzel A;Pinto RM;Kriplani N;Craig N;Hastie CJ;Davies P;Digard P;Thiel V;Tait-Burkard C |
View
More |
| 37705731
|
The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein. |
Front Microbiol |
2023 |
Piacentini S;Riccio A;Santopolo S;Pauciullo S;La Frazia S;Rossi A;Rossignol JF;Santoro MG |
View
More |
